Company Overview

Provectus Biopharmaceuticals, Inc. is a development-stage biopharmaceutical company dedicated to investigating potential therapeutics for cancer and inflammatory dermatoses.

Investor Contacts

Our Contact Form Mailing Address

Telephone: +1 (866) 594-5999
Fax: +1 (866) 998-0005
info@pvct.com

Provectus Biopharmaceuticals, Inc.
10025 Investment Drive, Suite 250
Knoxville, TN 37932

Investor Relations Media Relations

Provectus Biopharmaceuticals, Inc.
Email: investorrelations@pvct.com
Phone: +1 (866) 594-5999 x1

Provectus Biopharmaceuticals, Inc.
E-mail: mediarelations@pvct.com
Phone: +1 (866) 594-5999 x4

Transfer Agent

(i.e. stockholder records, transfer, change of address, etc.)
Broadridge Corporate Issuer Solutions, Inc.
P.O. Box 1342
Brentwood, NY 11717
E-mail: shareholder@broadridge.com
Telephone: +1 (877) 830-4936
Fax: +1 (215) 553-5402

Stock Performance

Today's Open 0.04
Volume 40,622
Day Range 0.04 - 0.05
52 Week Range 0.03 - 0.07
Bid/Ask 0.04 / 0.05
Bid/Ask Size 10,000 X 75,000
Previous Close 0.04
Market Cap 17.42 million
Shares Outstanding 390.69 million
Dividend/Yield 0.00 / 0.00%
EPS (TTM) -0.02
P/E Ratio (TTM) N/A

Recent XBRL Filings

Filing Date Form Type Description View
May 13, 2020 10-Q Quarterly report htmlhtml   pdfpdf   xbrlxbrl  
Mar 05, 2020 10-K Annual report htmlhtml   pdfpdf   xbrlxbrl  
Nov 12, 2019 10-Q Quarterly report htmlhtml   pdfpdf   xbrlxbrl  
Aug 08, 2019 10-Q Quarterly report htmlhtml   pdfpdf   xbrlxbrl  
May 13, 2019 10-Q Quarterly report htmlhtml   pdfpdf   xbrlxbrl